BioNexus Gene Lab Corp. (BGLC) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -147.67K | 961.06K | -1.23M | -737.91K | -824.07K | -54.32K | -1.42M | -672.27K | -37.15K | -261.91K | -899.35K | -23.82K | -116.52K | 474.47K | 308.89K | -187.66K | -37.84K | 483.01K | 315.87K | -905.14K |
| Operating CF Margin % | -646.49% | 198.66% | -48.48% | -32.65% | -38.56% | -2.15% | -54.1% | -34.05% | -1.56% | -11.52% | -35.22% | -0.93% | -4.9% | 16.71% | 12% | -7.55% | -1.25% | 14.88% | 8.83% | -29.27% |
| Operating CF Growth % | 82.08% | 1869.26% | 13.34% | -9.76% | -2118.05% | 79.26% | -58.24% | -2721.96% | 68.11% | -155.2% | -391.15% | 87.31% | -207.93% | -1.77% | -2.21% | 79.27% | -132.78% | -32.34% | -58.15% | -475.8% |
| Net Income | -543.58K | -1.04M | -708.99K | -616.17K | -623.33K | -348.32K | -1.35M | 199.1K | -103.76K | 307.42K | -2.61M | -259.25K | -69.07K | -156.97K | -77.4K | -138.66K | 17.07K | 89.24K | 295.32K | 28.26K |
| Depreciation & Amortization | 43.88K | 43.2K | 43.35K | 41.73K | 40.02K | 43.02K | 49.08K | 31.46K | 29.59K | 29.66K | 29.29K | 24.61K | 24.87K | 26.06K | 25.83K | 26.88K | 26.65K | 26.52K | 26.82K | 39.83K |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -88.95K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 175.75K | 802.89K | 148.27K | -51.13K | 70.02K | -187.59K | -126.07K | -576.5K | 33.1K | -522.47K | 1.57M | 183.91K | -44.32K | -134.77K | 53.81K | 59.42K | -3.45K | 5.15K | -1.04K | 16.79K |
| Working Capital Changes | 176.27K | 1.15M | -715.91K | -112.34K | -310.79K | 438.56K | -744 | -326.33K | 3.92K | 12.44K | 106.64K | 26.91K | -28K | 740.15K | 306.64K | -135.3K | -78.1K | 362.1K | -5.22K | -990.02K |
| Change in Receivables | 243.02K | 944.7K | 204.31K | -255.72K | -112.61K | -78.56K | 139.92K | 109.83K | -112.47K | 145.14K | 151.38K | 18.78K | 335.51K | -99.75K | 112.24K | 161.34K | 330.32K | 777.77K | -307.99K | -293.41K |
| Change in Inventory | 9.55K | 330.75K | 208.18K | -36.48K | 209.48K | 452 | -356.07K | 43.95K | 60.82K | -29.89K | 57.46K | -266.14K | 78.17K | 118.14K | 416.25K | 136.71K | -126.99K | -34.24K | 215.46K | -233.94K |
| Change in Payables | 187.89K | 0 | -1.11M | 0 | 0 | 462.17K | 200.59K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -427.06K | 0 | 0 | 0 | 0 |
| Cash from Investing | -13.99K | -5.72K | 990.45K | -28.53K | -15.65K | 485.68K | -221.94K | 63.31K | 3.65K | -13.75K | -360.71K | -3.06K | -5.06K | -49.9K | 18.36K | -233.91K | -197.13K | -76.29K | -58.58K | -59.88K |
| Capital Expenditures | -325 | -977 | -5.48K | -21.46K | -9.05K | -4.02K | -199.19K | -1.83K | -21.95K | -937 | -134K | -14.36K | -102 | -17.03K | -3.66K | -1.29K | -32.19K | -1.28K | -410 | -666 |
| CapEx % of Revenue | 1.42% | 0.2% | 0.22% | 0.95% | 0.42% | 0.16% | 7.57% | 0.09% | 0.92% | 0.04% | 5.25% | 0.56% | 0% | 0.6% | 0.14% | 0.05% | 1.06% | 0.04% | 0.01% | 0.02% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -13.66K | 360 | -15.87K | 8.63K | 8.93K | -77.77K | 1.59K | 89.08K | 8.95K | 12.52K | 29.1K | 11.1K | 8.69K | 80.86K | 15.2K | 0 | 7.23K | 8.56K | 2.42K | 16.52K |
| Cash from Financing | 59.71K | 266.54K | 34.19K | -1.03K | -860 | 139.61K | -196.98K | 175.41K | 26.93K | 11.12K | 5.75M | -2.43K | -1.78K | 0 | -1.74K | 115.96K | 0 | -4.96K | -6.08K | -8.63K |
| Debt Issued (Net) | -21.01K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -34.04K | 0 | 21.34K | -6K | -6.8K |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.75M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 80.72K | 266.54K | 34.19K | -1.03K | -860 | 139.61K | -196.98K | 175.41K | 26.93K | 11.12K | -2.58K | -2.43K | -1.78K | 0 | -1.74K | 150K | 0 | -26.3K | -84 | -1.84K |
| Net Change in Cash | -74.74K | 1.13M | -164.22K | -552.25K | -797.53K | 240.21K | -1.28M | -476.49K | -79.02K | -217.55K | 4.39M | -214.53K | -145.65K | 656.6K | 121.94K | -503.99K | -279.6K | 423.52K | 217.69K | -991.95K |
| Free Cash Flow | -148K | 960.09K | -1.24M | -759.37K | -833.12K | -58.34K | -1.62M | -674.11K | -59.1K | -262.85K | -1.03M | -38.18K | -116.62K | 457.44K | 305.23K | -188.96K | -70.03K | 481.73K | 315.46K | -905.81K |
| FCF Margin % | -647.93% | 198.46% | -48.7% | -33.6% | -38.98% | -2.31% | -61.68% | -34.14% | -2.48% | -11.56% | -40.47% | -1.49% | -4.91% | 16.11% | 11.85% | -7.6% | -2.31% | 14.84% | 8.82% | -29.29% |
| FCF Growth % | 82.24% | 1745.67% | 23.64% | -12.65% | -1309.73% | 77.8% | -56.99% | -1665.65% | 49.32% | -157.46% | -438.55% | 79.8% | -66.53% | -5.04% | -3.24% | 79.14% | -161.1% | 64.82% | -58.2% | -476.23% |
| FCF per Share | -0.06 | 0.52 | -0.69 | -0.42 | -0.46 | -0.03 | -0.90 | -0.38 | -0.03 | -0.15 | -0.62 | -0.03 | -0.08 | 0.32 | 0.21 | -0.13 | -0.05 | 0.34 | 0.22 | -0.63 |
| FCF Conversion (FCF/Net Income) | 0.27x | -0.93x | 1.74x | 1.20x | 1.32x | 0.16x | 1.06x | -3.38x | 0.36x | -0.85x | 0.34x | 0.09x | 1.69x | -3.02x | -3.99x | 1.35x | -2.22x | 5.41x | 1.07x | -32.03x |
| Interest Paid | 269 | 315 | 3.38K | 1.62K | 1.54K | 0 | 0 | 1.83K | 2.71K | -869 | 4.26K | 3.04K | 2.44K | 4.76K | 2.07K | 0 | 3.33K | 3.99K | 2.15K | 3.48K |
| Taxes Paid | 0 | 154 | 2.15K | 7.59K | 4.92K | 0 | 0 | 12.26K | 14.52K | 19.16K | 17.17K | 18.2K | 12.44K | 46.85K | 50.05K | 0 | 41.95K | 132.4K | 50.12K | 7.81K |